Personalized Critical Care in Lung Disease
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Critical Care".
Deadline for manuscript submissions: 25 June 2025 | Viewed by 57
Special Issue Editor
Interests: lung diseases; sepsis; ARDS; lung fibrosis
Special Issue Information
Dear Colleagues,
The Special Issue “Personalized Critical Care in Lung Disease” aims to explore innovative approaches in the management of lung diseases through tailored critical care strategies. With advances in technology and a deeper understanding of patient-specific factors, personalized medicine is becoming integral in optimizing treatment outcomes for patients with respiratory conditions. This Special Issue will feature original research and reviews that highlight the role of individualized care plans, risk stratification, and the integration of biomarkers in clinical decision-making. Topics may include, but need not be limited to, personalized ventilation strategies, targeted pharmacotherapy, the use of artificial intelligence in monitoring and treatment, and the implications of genetics and comorbidities in lung disease management. By fostering discussions around these advancements, this Special Issue aims to contribute to the evolving landscape of critical care in lung disease and ultimately enhance patient outcomes.
Dr. Yeo Hye Ju
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- critical care
- lung disease
- biomarkers
- risk stratification
- ventilation strategies
- artificial intelligence
- pharmacotherapy
- respiratory management
- patient outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
